首页> 美国卫生研究院文献>Molecular Metabolism >Liver-specific Prkn knockout mice are more susceptible to diet-induced hepatic steatosis and insulin resistance
【2h】

Liver-specific Prkn knockout mice are more susceptible to diet-induced hepatic steatosis and insulin resistance

机译:肝脏特异性PRKN敲除小鼠更易于饮食诱导的肝脏脂肪变性和胰岛素抵抗

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

PARKIN is an E3 ubiquitin ligase that regulates mitochondrial quality control through a process called mitophagy. Recent human and rodent studies suggest that loss of hepatic mitophagy may occur during the pathogenesis of obesity-associated fatty liver and contribute to changes in mitochondrial metabolism associated with this disease. Whole-body Prkn knockout mice are paradoxically protected against diet-induced hepatic steatosis; however, liver-specific effects of Prkn deficiency cannot be discerned in this model due to pleotropic effects of germline Prkn deletion on energy balance and subsequent protection against diet-induced obesity. We therefore generated the first liver-specific Prkn knockout mouse strain (LKO) to directly address the role of hepatic Prkn.
机译:Parkin是一种e3泛素连接酶,通过称为mitophy的过程调节线粒体质量控制。最近的人类和啮齿动物的研究表明,在肥胖相关脂肪肝的发病机制期间可能发生肝脏影响的损失,并有助于与这种疾病相关的线粒体代谢的变化。全身PRKN敲除小鼠是针对饮食诱导的肝脏脂肪化的矛盾保护;然而,由于种系PRKN缺失对能量平衡和随后的饮食诱导的肥胖保护,因此在该模型中不能辨别PRKN缺乏的肝脏特异性效果。因此,我们产生了第一个肝脏特异性PRKN敲除小鼠菌株(LKO),直接解决肝PRKN的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号